Trung Huynh
Stock Analyst at RBC Capital
(4.82)
# 453
Out of 4,712 analysts
298
Total ratings
75.7%
Success rate
22.7%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Initiated Coverage: Buy | 9,000p → 14,500p | 11,650p | +24.46% | 14 | Sep 9, 2026 | |
| SWX: NOVN Novartis AG | Downgraded: Hold | CHF 90.00 → CHF 120.00 | CHF 111.66 | +7.47% | 11 | Sep 8, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | CHF 350.00 → CHF 400.00 | CHF 347.70 | +15.04% | 13 | Sep 8, 2026 | |
| EPA: SAN Sanofi | Initiated Coverage: Hold | €96.00 → €80.00 | €74.24 | +7.76% | 17 | Sep 8, 2026 | |
| LON: GSK GSK plc | Downgraded: Hold | 1,400p → 1,975p | 1,804p | +9.51% | 14 | Sep 8, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $64 | $64.41 | -0.64% | 25 | Sep 1, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $150 | $147.53 | +1.67% | 23 | Aug 25, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,500 | $1,124.21 | +33.43% | 26 | Aug 5, 2026 | |
| PFE Pfizer | Reiterated: Hold | $25 | $27.78 | -10.01% | 38 | Aug 4, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $250.91 | +11.59% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $287 | $267.08 | +7.46% | 5 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $595 → $660 | $807.65 | -18.28% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $25 | $0.701 | n/a | 4 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 → $140 | $128.80 | n/a | 10 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $326 → $317 | $391.27 | n/a | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.2 → $1 | $1.84 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $38 | $38.78 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $2.91 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $12 | $7.64 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.85 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €10.00 → €13.50 | €9.96 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 700.00 → CHF 580.00 | CHF 538.00 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €44.00 → €40.00 | €52.00 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €14.00 → €12.00 | €10.08 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €105.00 | €158.50 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €57.00 | €49.26 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $31 | $7.82 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €165.00 | €132.70 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $73 | $44.56 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.47 | $33.04 | n/a | 2 | Jun 25, 2020 |
AstraZeneca PLC
Sep 9, 2026
Initiated Coverage: Buy
Price Target: 9,000p → 14,500p
Current: 11,650p
Upside: +24.46%
Novartis AG
Sep 8, 2026
Downgraded: Hold
Price Target: CHF 90.00 → CHF 120.00
Current: CHF 111.66
Upside: +7.47%
Roche Holding AG
Sep 8, 2026
Reiterated: Buy
Price Target: CHF 350.00 → CHF 400.00
Current: CHF 347.70
Upside: +15.04%
Sanofi
Sep 8, 2026
Initiated Coverage: Hold
Price Target: €96.00 → €80.00
Current: €74.24
Upside: +7.76%
GSK plc
Sep 8, 2026
Downgraded: Hold
Price Target: 1,400p → 1,975p
Current: 1,804p
Upside: +9.51%
Bristol-Myers Squibb Company
Sep 1, 2026
Reiterated: Hold
Price Target: $64
Current: $64.41
Upside: -0.64%
Merck & Co.
Aug 25, 2026
Reiterated: Hold
Price Target: $150
Current: $147.53
Upside: +1.67%
Eli Lilly and Company
Aug 5, 2026
Reiterated: Buy
Price Target: $1,500
Current: $1,124.21
Upside: +33.43%
Pfizer
Aug 4, 2026
Reiterated: Hold
Price Target: $25
Current: $27.78
Upside: -10.01%
AbbVie
Jul 31, 2026
Reiterated: Buy
Price Target: $280
Current: $250.91
Upside: +11.59%
Jul 21, 2026
Reiterated: Buy
Price Target: $175 → $287
Current: $267.08
Upside: +7.46%
Nov 7, 2025
Reiterated: Hold
Price Target: $595 → $660
Current: $807.65
Upside: -18.28%
Aug 15, 2025
Reiterated: Buy
Price Target: $29 → $25
Current: $0.701
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $133 → $140
Current: $128.80
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $326 → $317
Current: $391.27
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $1.2 → $1
Current: $1.84
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $44 → $38
Current: $38.78
Upside: n/a
Apr 1, 2025
Reiterated: Buy
Price Target: $10 → $7
Current: $2.91
Upside: n/a
Mar 29, 2025
Reiterated: Buy
Price Target: $13 → $12
Current: $7.64
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $4
Current: $2.85
Upside: n/a
Aug 24, 2023
Reiterated: Hold
Price Target: €10.00 → €13.50
Current: €9.96
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: CHF 538.00
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: €44.00 → €40.00
Current: €52.00
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: €14.00 → €12.00
Current: €10.08
Upside: n/a
Apr 13, 2022
Reiterated: Hold
Price Target: €105.00
Current: €158.50
Upside: n/a
Dec 13, 2021
Reiterated: Hold
Price Target: €57.00
Current: €49.26
Upside: n/a
Aug 4, 2021
Reiterated: Buy
Price Target: $29 → $31
Current: $7.82
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: €165.00
Current: €132.70
Upside: n/a
Oct 12, 2020
Reiterated: Buy
Price Target: $56 → $73
Current: $44.56
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.47
Current: $33.04
Upside: n/a